Image via Wikipedia

Common Sense Ltd., a developer and manufacturer of proprietary diagnostic products for women’s healthcare, recently introduced in the United States a novel solution for clinicians who wish to screen women for vaginitis.

Designed for use in doctor’s offices, the VS-SENSE™ swab based test detects within seconds, by color change, elevated vaginal acidity levels associated with Bacterial Vaginosis (BV) and the sexually transmitted disease Trichomonas. The VS-SENSE™ Test has an accuracy rate of more than 90 percent and offers an alternative to time-consuming clinical tests as well as expensive laboratory tests that doctors relied on in the past.

The VS-SENSE™ Test is recommended for use in all cases of abnormal vaginal discharge. The VS-SENSE™ Test may also be used before procedures such as in-vitro fertilization and hysterectomies. If BV or Trichomonas is detected, doctors can recommend treatment and also may wish to delay these procedures in order to achieve the best possible outcome for their patients. Patent protected, the VS-SENSE™ Test received 510(k) clearance by the FDA in August 2009, and is already widely used in Israel and various European countries.

“Doctors love the VS-SENSE™ Test because it is so easy to use,” says Amir Karp, Common Sense’s Director of Marketing and Business Development. “They can now diagnose and treat their patients more accurately and more cost effectively than ever before and help ensure that their patients enjoy good feminine health.”

BV is one of the most common vaginal infections in women, and in close to 20 percent, BV patients are asymptomatic. Treatment is especially important for pregnant women, particularly those who have delivered premature or low birth-weight babies in the past. Trichomonas is one of the most common sexually transmitted diseases. Left untreated, women suffering from BV or Trichomonas are more susceptible to the HIV virus and when pregnant may deliver premature or low birth-weight babies.

Headquartered in Israel, Common Sense Ltd. was established in 1999 to develop and manufacture proprietary diagnostic products for women’s healthcare. In addition to the VS-SENSE™ Test, the company has a full line of non-intrusive diagnostic products that will soon be available either at clinician sites or sold over the counter. For more information, visit www.cs-commonsense.com, or call 516-741-5252.

# # #